EYECARE COOKSTOWN LTD

Company Registration Number:
NI606807 (Northern Ireland)

Unaudited abridged accounts for the year ended 30 April 2023

Period of accounts

Start date: 01 May 2022

End date: 30 April 2023

EYECARE COOKSTOWN LTD

Contents of the Financial Statements

for the Period Ended 30 April 2023

Balance sheet
Notes

EYECARE COOKSTOWN LTD

Balance sheet

As at 30 April 2023


Notes

2023

2022


£

£
Called up share capital not paid: 0 0
Fixed assets
Intangible assets: 3 104,402 113,102
Tangible assets: 4 3,250 3,473
Investments:   0 0
Total fixed assets: 107,652 116,575
Current assets
Stocks: 20,853 19,530
Debtors:   65,970 61,440
Cash at bank and in hand: 6,239 11,368
Investments:   0 0
Total current assets: 93,062 92,338
Creditors: amounts falling due within one year:   (157,618) (159,245)
Net current assets (liabilities): (64,556) (66,907)
Total assets less current liabilities: 43,096 49,668
Creditors: amounts falling due after more than one year:   (35,202) (40,238)
Provision for liabilities: (535) 0
Total net assets (liabilities): 7,359 9,430
Capital and reserves
Called up share capital: 100 100
Profit and loss account: 7,259 9,330
Shareholders funds: 7,359 9,430

The notes form part of these financial statements

EYECARE COOKSTOWN LTD

Balance sheet statements

For the year ending 30 April 2023 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 19 January 2024
and signed on behalf of the board by:

Name: Christopher Mackey
Status: Director

The notes form part of these financial statements

EYECARE COOKSTOWN LTD

Notes to the Financial Statements

for the Period Ended 30 April 2023

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

EYECARE COOKSTOWN LTD

Notes to the Financial Statements

for the Period Ended 30 April 2023

2. Employees

2023 2022
Average number of employees during the period 4 3

EYECARE COOKSTOWN LTD

Notes to the Financial Statements

for the Period Ended 30 April 2023

3. Intangible Assets

Total
Cost £
At 01 May 2022 174,003
At 30 April 2023 174,003
Amortisation
At 01 May 2022 60,901
Charge for year 8,700
At 30 April 2023 69,601
Net book value
At 30 April 2023 104,402
At 30 April 2022 113,102

EYECARE COOKSTOWN LTD

Notes to the Financial Statements

for the Period Ended 30 April 2023

4. Tangible Assets

Total
Cost £
At 01 May 2022 54,340
Additions 377
At 30 April 2023 54,717
Depreciation
At 01 May 2022 50,867
Charge for year 600
At 30 April 2023 51,467
Net book value
At 30 April 2023 3,250
At 30 April 2022 3,473

EYECARE COOKSTOWN LTD

Notes to the Financial Statements

for the Period Ended 30 April 2023

5. Related party transactions